최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Turkish journal of biology = Türk biyoloji dergisi, v.44 no.3, 2020년, pp.203 - 214
BALCIOĞLU, Bertan Koray (Genetic Engineering and Biotechnology Institute, Marmara Research Center, TÜ) , DENİZCİ (Bİ) , ÖNCÜ, Melis (TAK, Kocaeli Turkey) , ÖZTÜRK, Hasan Ümit (Genetic Engineering and Biotechnology Institute, Marmara Research Center, TÜ) , YÜCEL, Fatıma (Bİ) , KAYA, Filiz (TAK, Kocaeli Turkey) , SERHATLI, Müge (Genetic Engineering and Biotechnology Institute, Marmara Research Center, TÜ) , ÜLBEĞİ (Bİ) , POLAT, Hivda (TAK, Kocaeli Turkey) , TEKİN, Şaban (Genetic Engineering and Biotechnology Institute, Marmara Research Center, TÜ) , ÖZDEMİR BAHADIR, Aylin (Bİ)
In December 2019 a novel coronavirus was detected in Wuhan City of Hubei Province-China. Owing to a high rate of transmission from human to human, the new virus called SARS-CoV-2 differed from others by its unexpectedly rapid spread. The World Health Organization (WHO) described the most recent cor...
Ahmadzadeh V Farajnia S Feizi MA Nejad RA 2014 Antibody humanization methods for development of therapeutic applications Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 33 67 24746146
Akamatsu Y Pakabunto K Xu Z Zhang Y Tsurushita N 2007 Whole IgG surface display on mammalian cells: application to isolation of neutralizing chicken monoclonal anti-IL-12 antibodies Journal of Immunological Methods 327 40 17719061
Bahadir AO Balcioglu BK Uzyol KS Hatipoglu I Sogut I 2011 Phage displayed HBV core antigen with immunogenic activity Applied Biochemistry and Biotechnology 165 1437 21915589
Barnard DL Day CW Bailey K Heiner M Montgomery R 2006 Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice Antiviral Chemistry and Chemotherapy 17 275 17176632
BerryJ D Jones S Drebot MA Andonov A Sabara M 2004 Development and characterisation of neutralising monoclonal antibody to the SARS-coronavirus Journal of Virological Methods 120 87 15234813
Bisht H Roberts A Vogel L Bukreyev A Collins PL 2004 Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice Proceedings of the National Academy of Sciences of the United States of America 101 6641 15096611
Casadevall A Pirofski LA 2020 The convalescent sera option for containing COVID-19 Journal of Clinical Investigation 130 1545 32167489
Carmen S Jermutus L 2002 Concepts in antibody phage display Briefings in Functional Genomics and Proteomics 1 189 15239904
Chen L Xiong J Bao L Shi Y 2020 Convalescent plasma as a potential therapy for COVID-19. The Lancet Infectious Diseases 20 398 32113510
Chen Z Zhang L Qin C Ba L Yi CE 2005 Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region Journal of Virology 79 2678 15708987
Cheong WS Leow CY Majeed ABA Leow CH 2020 Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody International Journal of Biological Macromolecules 147 369 31926922
Davey RT Dodd L Proschan MA Neaton J Nordwall JN 2016 The PREVAIL II Writing Group, for the Multi-National PREVAIL II Study Team ( New England Journal of Medicine 375 1448 27732819
King DJ Bowers PM Kehry MR Horlick RA 2014 Mammalian cell display and somatic hypermutation in vitro for human antibody discovery Current Drug Discovery Technologies 11 56 23978037
Day CW Baric R Cai SX Frieman M Kumaki Y 2009 A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo Virology 395 210 19853271
Duan K Liu B Li C Zhang H Yu T 2020 Effectiveness of convalescent plasma therapy in severe Covid-19 patients Proceedings of the National Academy of Sciences 117 9490
Erdag B Balcioglu KB Kumbasar A Celikbicak O Zeder-Lutz G 2007 Novel short peptides isolated from phage display library inhibit vascular endothelial growth factor activity Molecular Biotechnology 35 51 17401149
Erdag B Balcioglu BK Bahadir AO Serhatli M Kacar O 2011 Identification of novel neutralizing single-chain antibodies against vascular endothelial growth factor receptor 2 Biotechnology and Applied Biochemistry 58 412 22172104
Ertekin O Guloglu FB Pirincci S Tuglu S Akcael E 2013 Antibody based systems for the determination of mycotoxins in food and feed Current Opinion in Biotechnology 24 (Supplement 1 23 23
Folgori A Tafi R Meola A Felici F Galfre G 1994 A general strategy to identify mimotopes of pathological antigens using only random peptide libraries and human sera The EMBO Journal 13 2236 7514533
Fuentes M Palomo JM Mateo C Venteo A Sanz A 2005 Optimization of the modification of carrier proteins with aminated haptens Journal of Immunological Methods 307 144 16263130
Galfre G Milstein C Part B 1982 Preparation of monoclonal antibodies: strategies and procedures Methods in Enzymology 73 3
Glass WG Subbarao K Murphy B Murphy PM 2004 Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARSCoV) pulmonary infection of mice The Journal of Immunology 173 4030 15356152
Gorny MK 2012 Human Hybridoma Technology Antibody Technology Journal 2 1
Greenough TC Carville A Coderre J Somasundaran M Sullivan JL 2005 Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus American Journal of Pathology 167 455 16049331
Ho M Nagata S Pastan I 2006 Isolation of anti-CD22 Fv with high affinity by Fv display on human cells Proceedings of the National Academy of Sciences 103 9637
Ho M Pastan I Totowa 2009 Display and selection of scFv antibodies on HEK-293T cells Antibody Phage Display. Methods in Molecular Biology (Methods and Protocols) 562 99
Hogan RJ Gao G Rowe T Bell P Flieder D 2004 Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1 Journal of Virology 78 11416 15452265
Huang J Doria-Rose NA Longo NS Laub L Lin C-L 2013 Isolation of human monoclonal antibodies from peripheral blood B cells Nature Protocols 8 1907 24030440
Iannolo G Minenkova O Petruzzelli R Cesareni G 1995 Modifying filamentous phage capsid: limits in the size of the major capsid protein Journal of Molecular Biology 248 835 7752244
Ju B Zhang Q Ge X Wang R Yu J 2020 Potent human neutralizing antibodies elicited by SARS-CoV-2 infection 10
Klasse PJ 2014 Neutralization of virus iInfectivity by antibodies: old problems in new perspectives Advances in Biology 157895 157895 27099867
Kim JH Hong HJ 2012 Humanization by CDR grafting and specificity-determining residue grafting Methods in Molecular Biology 907 237 22907355
Kowalski M Guindon J Brazas L Moore C Entwistle J 2012 A phase II study of oportuzumab monatox: an immunotoxin therapy for patients with noninvasive urothelial carcinoma in situ previously treated with bacillus Calmette-Guerin The Journal of Urology 188 1712 22998907
Kuiken T Fouchier RA Schutten M Rimmelzwaan GF Van Amerongen G 2003 Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome Lancet 362 263 12892955
Lawler JV Endy TP Hensley LE Garrison A Fritz EA 2006 Cynomolgus macaque as an animal model for severe acute respiratory syndrome PLoS Medicine 3 e149 e149 16605302
Ledsgaard L Kilstrup M Karatt-Vellatt A McCafferty J Laustsen AH 2018 Basics of antibody phage display technology Toxins 10 236 236
Li H Liu SM Yu XH Tang SL Tang CK 2020 Coronavirus disease 2019 (COVID-19): current status and future perspectives International Journal of Antimicrobial Agents 105951 105951 32234466
Li J Sai M Berger M Chao Q Davidson D 2006 Human antibodies for immunotherapy development generated via a human B cell hybridoma technology Proceedings of the National Academy of Sciences of the United States of America 103 3557 16505368
Li K McCray PB 2020 ( Methods in Molecular Biology 161
Lim CC Woo PCY Lim TS 2019 Development of a phage display panning strategy utilizing crude antigens: isolation of MERS-CoV nucleoprotein human antibodies Scientific Reports 9 6088 6088 30988390
Liu X Gao F Gou L Chen Y Gu Y 2020 Neutralizing antibodies isolated by a site-directed screening have potent protection on SARS-CoV-2 infection 10
Luke T Wu H Zhao J Channappanavar R Coleman CM 2016 Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo Science Translational Medicine 8 326ra21 326ra21
Martina BE Haagmans BL Kuiken T Fouchier RA Rimmelzwaan GF 2003 Virology: SARS virus infection of cats and ferrets Nature 425 915 915 14586458
McAuliffe J Vogel L Roberts A Fahle G Fischer S 2004 Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys Virology 330 8 15527829
McCafferty J Griffiths AD Winter G Chiswell DJ 1990 Phage antibodies: filamentous phage displaying antibody variable domains Nature 348 552 2247164
McCray PB Pewe L Wohlford-Lenane C Hickey M Manzel L 2007 Lethal infection of K18-hACE2 mice infected with severe acute respiratory syndrome coronavirus Journal of Virology 81 813 17079315
Mimmi S Maisano D Quinto I Iaccino E 2019 Phage display: an overview in context to drug discovery Trends in Pharmacological Sciences 40 87 30606501
Nancy T Janine T Nancy T Janine T 2004 Bacteriophages Australia: Blackwell Science Ltd 105
Omar N Lim TS Hust M Totowa 2018 Construction of Naive and Immune Human Fab Phage-Display Library Phage Display. Methods in Molecular Biology 1701 25 29116498
Kaye M Druce J Tran T Kostecki R Chibo D 2006 SARS-associated coronavirus replication in cell lines Emerging Infectious Diseases 12 128 16494729
Qin C Wang J Wei Q She M Marasco WA 2005 An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus Journal of Pathology 206 251 15892035
Ratnam S Gadag R West R Burris J Oates E 1995 Comparison of commercial enzyme immunoassay kits with plaque reduction neutralization test for detection of measles virus antibody Journal of Clinical Microbiology 33 811 7790442
Roberts A Paddock C Vogel L Butler E Zaki S 2005a Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans Journal of Virology 79 5833 15827197
Roberts A Vogel L Guarner J Hayes N Murphy B 2005b Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters Journal of Virology 79 503 15596843
Roberts A Deming D Paddock CD Cheng A Yount B 2007 A mouse adapted SARS-coronavirus causes disease and mortality in BALB/C mice PLoS Pathogens 3 e5 e5 17222058
Roberts A Lamirande EW Vogel L Jackson JP Paddock CD 2008 Animal models and vaccines for SARS-CoV infection Virus Research 133 20 17499378
Beerli BB Bauer M Buser RB Gwerder M Muntwiler S 2008 Isolation of human monoclonal antibodies by mammalian cell display Proceedings of the National Academy of Sciences of the United States of America 105 14336 18812621
Rowe T Gao G Hogan RJ Crystal RG Voss TG 2004 Macaque model for severe acute respiratory syndrome Journal of Virology 78 11401 15452262
Safdari Y Farajnia S Asgharzadeh M Khalili M 2013 Antibody humanization methods - a review and update Biotechnology and Genetic Engineering Reviews 29 175 24568279
Shanehbandi D Majidi J Kazemi T Baradaran B Aghebati-Maleki L 2017 Cloning and molecular characterization of the cDNAs encoding the variable regions of an anti-CD20 monoclonal antibody Human Antibodies 26 1 28269762
Shen C Wang Z Zhao F Yang Y Li J 2015 Treatment of critically ill patients with COVID-19 with convalescent plasma JAMA 323 1582
Shernan SK Fitch JC Nussmeier NA Chen JC Rollins SA 2004 Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypass The Annals of Thoracic Surgery 77 942 14992903
Schmidt NJ Dennis J Lennette EH 1976 Plaque reduction neutralization test for human cytomegalovirus based upon enhanced uptake of neutral red by virus-infected cells Journal of Clinical Microbiology 4 61 182716
Shukra AM Sridevi NV Dev C Kapil M 2014 Production of recombinant antibodies using bacteriophages European Journal of Microbiology and Immunology 4 91 24883194
Scott AS Crowe JE 2015 Use of human hybridoma technology to isolate human monoclonal antibodies Microbiology Spectrum 3
Siu YL Teoh KT Lo J Chan CM Kien F 2008 The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles Journal of Virology 82 11318 18753196
Stephen JT Nisalak A Anderson KB Libraty DH Kalayanarooj S 2009 Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: how alterations in assay conditions impact performance The American Journal of Tropical Medicine and Hygiene 81 825 19861618
Smith GP 1985 Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface Science 1228 1315
Smith GP Petrenko VA 1997 Phage Display. Chemical Reviews 97 391 11848876
Subbarao K McAuliffe J Vogel L Fahle G Fischer S 2004 Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice Journal of Virology 78 3572 15016880
Ter Meulen J Bakker AB Van den Brink EN Weverling GJ Martina BE 2004 Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets Lancet 363 2139 15220038
Traggiai E Becker S Subbaro K Kolesnikova L Uematsu Y 2004 An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus Nature Medicine 10 871
Waldmann H Totowa 2014 Human Monoclonal Antibodies: The Residual Challenge of Antibody Immunogenicity Human Monoclonal Antibodies, Methods and Protocols. Methods in Molecular Biology 1060 1
Wan Y Shang J Sun S Tai W Chen J 2020 Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry Journal of Virology 94 19 19
Wang C Li W Drabek D Okba NMA Haperen R 2020 A human monoclonal antibody blocking SARS-CoV-2 infection Nature Communications 11 2251 2251
Widjaja I Wang C Van Haperen R Gutierrez-Alvarez J Van Dieren 2019 Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein Emerging Microbes and Infections 8 516 30938227
Wilson PC Andrews SF 2012 Tools to therapeutically harness the human antibody response Nature Reviews Immunology 12 709
Wong SK Li W Moore MJ Choe H Farzan M 2004 A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2 Journal of Biological Chemistry 279 3197 14670965
Wrapp D Wang N Corbett KS Goldsmith JA Hsieh CL 2020a Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation Science 13 1260
Wrapp D De Vlieger D Corbett KS Torres GM Breedam WV 2020 Structural basis for potent neutralization of betacoronaviruses by single-domain camelid antibodies Cell 181 1 32243785
Wu F Wang A Liu M Wang Q Chen J 2020 Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications MedRxiv.
2020 doi: 10
Wu Y Li C Xia S Tian X Kong Y 2020 Identification of human single-domain antibodies against SARS-CoV-2 Cell Host and Microbe 27 1 31951820
Xiong H Wu J Cao J Yang R Ma J 2020 Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells BioRxiv (preprint)
Zeng X Lingfang Li Lin Jing Li Xinlei 2020 Isolation of a human monoclonal antibody specific for the receptor-binding domain of SARS-CoV-2 using a competitive phage biopanning strategy Antibody Therapeutics 3 95
Zhao G He L Sun S Qiu H Tai W Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity A Novel 2018 Protective Efficacy against MERS-CoV Journal of Virology 92 18 18
Zhou P Yang XL Wang XG Hu B Zhang L 2020 A pneumonia outbreak associated with a new coronavirus of probable bat origin Nature 579 270 32015507
Zhou C Jacobsen FW Cai L Chen Q Shen D 2020 Development of a novel mammalian cell surface antibody display platform mAbs 2 508 518
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.